Insider trades
Jack W. Callicutt, CFO of Galectin Therapeutics GALT, has filed 0 purchases and 22 sales on the open market. Over the past 12 months that comes to a net sale of $944.3K. The latest trade was on 01/16.
Jack W. Callicutt
CFO
- Company
- Galectin Therapeutics GALT
- First filing
- 23/01/30
- Trades
- 69 trades
- Buys / sales
- 0 / 22
- 12-month net buying
- −$944.3K
- Last trade
- 01/16
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
GALT | Open-market sale10b5-1 plan | 01/02–01/06 | 01/06 | 60,000 sh3 trades | $3.89avg. | $233,492.78 | −88.7% |
GALT | Open-market sale10b5-1 plan | 25/11/17–25/11/18 | 25/11/19 | 77,920 sh5 trades | $6.14avg. | $478,656.5 | −91.1% |
GALT | Open-market sale10b5-1 plan | 25/11/10 | 25/11/12 | 5,291 sh3 trades | $6.03avg. | $31,885.93 | −41.0% |
GALT | Open-market sale10b5-1 plan | 25/11/05 | 25/11/07 | 600 sh3 trades | $6.00avg. | $3,600 | −7.3% |
GALT | Open-market sale10b5-1 plan | 25/11/03–25/11/04 | 25/11/05 | 32,439 sh6 trades | $6.06avg. | $196,676.13 | −81.0% |
| Open-market sale10b5-1 plan | 25/09/12 | 25/09/15 | 8,706 sh | $6.44 | $56,066.64 | −53.3% | |
| Open-market sale10b5-1 plan | 24/12/23 | 24/12/26 | 40,000 sh | $0.89 | $35,600 | −84.0% |